(Q40110977)

English

Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

author name string

Faye Yuan-yi Hsu

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Yi Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

W French Anderson

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Patrick B Johnston

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

240-248

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Major nucleolar proteins shuttle between nucleus and cytoplasm

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Hammerhead ribozyme-mediated cleavage of the fusion transcript NPM-ALK associated with anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL).

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Specific inhibition of bcr-abl gene expression by small interfering RNA.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

1 reference

https://api.crossref.org/works/10.1080%2F07357900701206372

21 January 2018

Identifiers

10.1080/07357900701206372

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40110977&oldid=2165018369"